Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Pharmaceutical Sterility Testing Market

Pharmaceutical Sterility Testing Market Size

Report ID: GMI9112
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Pharmaceutical Sterility Testing Market Size

Pharmaceutical Sterility Testing Market size was valued at USD 741.3 million in 2023 and is anticipated to witness growth at a CAGR of 10.8% between 2024 and 2032. The market is experiencing growth driven by increased demand for sterile products and biologics, such as vaccines and gene therapies.

To get key market trends

Download Free Sample

The market is expanding as pharmaceutical companies strive to comply with stringent regulatory requirements and quality standards. In addition, advances in testing methods, such as rapid microbiological testing and automated systems, enhance efficiency and accuracy, encouraging wider adoption and investment in these technologies. These factors collectively contribute to the expansion of this market. Furthermore, stringent regulatory requirements, increasing focus on patient safety, and the globalization of pharmaceutical supply chain supports the market growth.

Pharmaceutical sterility testing is a quality assurance process used to confirm that pharmaceutical products such as injectable drugs, biologics, vaccines, ophthalmic preparations, and medical devices are free from viable microorganisms. This testing is essential for ensuring the safety, efficacy, and integrity of pharmaceutical products, as well as compliance with regulatory standards.

Pharmaceutical Sterility Testing Market Report Attributes
Report Attribute	Details
Base Year:	2023
Pharmaceutical Sterility Testing Market Size in 2023:	USD 741.3 Million
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	10.8%
2032 Value Projection:	USD 1.8 Billion
Historical Data for:	2021 - 2023
No. of Pages:	224
Tables, Charts & Figures:	389
Segments covered:	Product, Test, Type, Sample, End-user, and Region
Growth Drivers:	Rising prevalence of infectious diseases Increasing outsourcing of sterility testing services Stringent regulatory requirements for pharmaceutical companies
Pitfalls & Challenges:	Complexity of testing procedures

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Pharmaceutical sterility testing market size was USD 741.3 million in 2023 and is expected to register 10.8% CAGR from 2024-2032 owing to the increased demand for sterile products and biologics, such as vaccines and gene therapies worldwide.

The kits & reagents segment recorded 52.1% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to provide comprehensive and convenient solutions.

North America pharmaceutical sterility testing industry reached USD 317.3 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to a strong pharmaceutical industry and stringent regulatory environment in the region.

Charles River Laboratories, Nelson Laboratories, LLC, Merck KGaA, Pacific BioLabs Inc., Rapid Micro Biosystems Inc., SGS Société Générale de Surveillance SA., STERIS Corporation, and Thermo Fisher Scientific Inc., are some of the major pharmaceutical sterility testing companies worldwide.